Psychemedics Cash Flow from Operating Activities 2010-2024 | PMD

Psychemedics cash flow from operating activities from 2010 to 2024. Cash flow from operating activities can be defined as a company's cash flows from operations.
Psychemedics Annual Cash Flow Ops
(Millions of US $)
2024 $1
2023 $-1
2022 $5
2021 $0
2020 $-4
2019 $4
2018 $8
2017 $9
2016 $9
2015 $5
2014 $4
2013 $6
2012 $3
2011 $4
2010 $3
2009 $2
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.000B $0.020B
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $20.544B 19.63
Encompass Health (EHC) United States $12.432B 24.83
DaVita (DVA) United States $9.837B 14.07
Elanco Animal Health (ELAN) United States $8.689B 19.43
Chemed (CHE) United States $6.617B 22.16
RadNet (RDNT) United States $5.277B 190.58
Option Care Health (OPCH) United States $4.518B 19.33
LifeStance Health (LFST) United States $2.139B 0.00
Addus HomeCare (ADUS) United States $2.102B 22.66
Astrana Health (ASTH) United States $1.680B 58.76
Aveanna Healthcare Holdings (AVAH) United States $1.471B 27.08
U.S Physical Therapy (USPH) United States $1.284B 32.12
Atai Life Sciences (ATAI) Germany $0.941B 0.00
Pennant (PNTG) United States $0.855B 30.18
Daxor (DXR) United States $0.052B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.049B 0.00